Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bulai

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 7, 2020
Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenibM P Konstantinou, P Lucas, C Uthurriague, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2013
Incidence and risk factors for treatment failure with infliximab in psoriasisH Escande, C Bulai Livideanu, A Steiner, et al.
Dermatology (Basel, Switzerland)|March 8, 2013
Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled studyM Lahfa, C Bulai-Livideanu, R Baran, et al.
Annales De Dermatologie Et De Venereologie|April 19, 2011
[Guide for therapeutic education program in psoriasis]S Balica, C Bernier, J Mazereeuw-Hautier, et al.
Annales De Dermatologie Et De Venereologie|March 30, 2024
Real-life management of psoriasis with biological agents during pregnancyC Tran, E Mahé, M Beylot-Barry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2019
Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort studyM Fradet, M Negretto, E Tournier, et al.
The British Journal of Dermatology|April 3, 2021
Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL<sup>-1</sup> : why we should investigate furtherF Jendoubi, J Shourick, M Negretto, et al.
The British Journal of Dermatology|April 20, 2012
Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in FranceA Maza, M A Richard, F Aubin, et al.
Dermatology (Basel, Switzerland)|September 21, 2013
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosisC Paul, D Coustou, M Lahfa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 4, 2016
Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective studyE Guinard, C Bulai Livideanu, H Barthélémy, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of the European Academy of Dermatology and Venereology : JEADV|August 7, 2020
Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenibM P Konstantinou, P Lucas, C Uthurriague, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2013
Incidence and risk factors for treatment failure with infliximab in psoriasisH Escande, C Bulai Livideanu, A Steiner, et al.
Dermatology (Basel, Switzerland)|March 8, 2013
Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled studyM Lahfa, C Bulai-Livideanu, R Baran, et al.
Annales De Dermatologie Et De Venereologie|April 19, 2011
[Guide for therapeutic education program in psoriasis]S Balica, C Bernier, J Mazereeuw-Hautier, et al.
Annales De Dermatologie Et De Venereologie|March 30, 2024
Real-life management of psoriasis with biological agents during pregnancyC Tran, E Mahé, M Beylot-Barry, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2019
Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort studyM Fradet, M Negretto, E Tournier, et al.
The British Journal of Dermatology|April 3, 2021
Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL<sup>-1</sup> : why we should investigate furtherF Jendoubi, J Shourick, M Negretto, et al.
The British Journal of Dermatology|April 20, 2012
Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in FranceA Maza, M A Richard, F Aubin, et al.
Dermatology (Basel, Switzerland)|September 21, 2013
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosisC Paul, D Coustou, M Lahfa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 4, 2016
Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective studyE Guinard, C Bulai Livideanu, H Barthélémy, et al.
Pageof 6